Pam Randhawa

Pam Randhawa is CEO and Founder of Empiriko, a biotech company focused on developing R&D technologies for drug discovery and home-based point-of-care devices for personalized patient treatment.

Pam has 20 years of experience in the healthcare and life sciences industries with expertise ranging from policy, corporate strategy, product development, analytics and marketing for Fortune 500 companies, startups and government. Prior to founding Empiriko, she co-founded AgroGreen Biofuels, an alternative biofuels technology company using agriculture waste.

Previously, Pam held several executive positions with major healthcare technology companies. She also served as an independent consultant to the State of Ohio, Department of Health, where she led a statewide taskforce for the Health Status of Ohioans for the State Health Plan to increase access and quality, reduce the cost of healthcare and improve public health in Ohio.

Pam serves on the Board of Directors of the Massachusetts Life Sciences Center (MLSC), a state investment agency responsible for $1 billion fund to support life sciences innovation and create STEM related jobs in Massachusetts. She also serves on the Board of Directors of the Massachusetts Biotech Technology Council and a member of the World Economic Forum’s Global Future Council on Biotechnology. She is a member of the NIH review panel for SBIR/STTR Commercialization Readiness Pilot Program and the Silent Spring Institute’s Leadership Council which studies the links between the environment and women’s health, with a focus on breast cancer. In addition, she serves on the Women’s Workforce Council, an initiative of Boston Mayor Marty Walsh to eliminate the gender wage gap. She serves as a judge for the Harvard Business School’s New Venture Competition and provides mentorship to startups and young professionals.

Pam holds a Bachelors Degree in economics from the University of Rajasthan, India, and received a Masters Degree from the Heinz School of Public Policy and Management at Carnegie-Mellon University.